Integra Holdings

Integra Holdings serves as an exclusive gateway for investment into early-stage life science research and technologies originating from the Hebrew University. Their investment approach is centered on identifying and evaluating promising innovations within Pharma Biotechnology, Medical Devices, Diagnostics, and AI. The firm aims to bridge the gap between academic research and the business world by providing a supportive and personalized approach to building successful ventures. They are focused on bringing academic excellence to market. Integra Holdings aims to de-risk early-stage technologies by leveraging their exclusive access and expertise in evaluating the potential of academic innovations. They actively work with researchers and entrepreneurs to translate scientific breakthroughs into commercially viable products. The firm's commitment extends beyond financial investment, encompassing guidance and support to navigate the complexities of the business landscape. By concentrating on technologies sourced from the Hebrew University, Integra Holdings benefits from a consistent pipeline of novel opportunities. Their specialized focus enables them to develop a deep understanding of the technologies they invest in, increasing their chances of identifying breakthroughs with significant market potential. This also allows them to foster close relationships with faculty and researchers, facilitating collaboration and knowledge sharing.

Pharma Biotechnology, Medical devices, Diagnostic, AI

Core thematic spaces, technologies, and target market segments of interest.